We provide honest, clear information and encourage patients to ask questions for better understanding of their treatment, ensuring complete clarity
Novel GLP-1-based Medications for Type 2 Diabetes and Obesity (Endocrine Reviews)
Unlike conventional supplements, BPC-157 works at the cellular signaling level , supporting repair processes throughout the body
Deficiency can cause fatigue, nerve issues, and memory problems
Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) Small-molecule NNMT inhibitor often discussed with metabolic protocols